These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5289827)

  • 1. Cytosine arabinoside therapy for acute myeloid leukaemia in adults.
    Buchanan JG
    N Z Med J; 1971 Sep; 74(471):153-9. PubMed ID: 5289827
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271).
    Bodey GP; Rodriguez V; Hart J; Freireich EJ
    Cancer Chemother Rep; 1970 Aug; 54(4):255-62. PubMed ID: 4946010
    [No Abstract]   [Full Text] [Related]  

  • 3. [Attempt at treatment of acute leukemias with cytosine-arabinoside according to Skipper's method].
    Schwarzenberg L; Mathé G; Hayat M; de Vassal F; Amiel JL; Cattan A; Schneider M; Schlumberger JR; Rosenfeld C; Jasmin C
    Nouv Rev Fr Hematol; 1969; 9(2):199-204. PubMed ID: 4239783
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytosine arabinoside as a single agent in the therapy of adult acute leukemia.
    Armentrout SA; Burns CP
    Am J Med Sci; 1974 Sep; 268(3):163-8. PubMed ID: 4531223
    [No Abstract]   [Full Text] [Related]  

  • 5. [A phase II study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia].
    Miyawaki S; Mizoguchi H; Tomonaga M; Kanamaru A; Tsukagoshi S; Nakamura T; Ohashi Y; Yoshida S; Ohno R
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2229-42. PubMed ID: 9881080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 7. Adult acute leukaemia--a suitable case for treatment?
    Hamblin TJ; Jones JV
    Bristol Med Chir J; 1973 Jan; 88(325):11-5. PubMed ID: 4520547
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemia.
    Slevin ML; Piall EM; Aherne GW; Johnston A; Sweatman MC; Lister TA
    Br J Clin Pharmacol; 1981 Oct; 12(4):507-10. PubMed ID: 6945865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytosine arabinoside in the treatment of acute myeloblastic leukaemia.
    Bailey CC; Geary CG; Israëls MC; Whittaker JA; Brown MJ; Weatherall DJ
    Lancet; 1971 Jun; 1(7712):1268-71. PubMed ID: 4104719
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitoxantrone and cytosine arabinoside in previously untreated adult patients with acute non-lymphocytic leukemia.
    Osman I; Akin U; Ismet A; Meral B; Hamdi A; Haluk K
    Haematologia (Budap); 1996; 27(2):93-7. PubMed ID: 14651226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-asparaginase and prednisolone pretreatment followed by rubidomycin and cytosine arabinoside for induction of remission in adult patients with acute myeloblastic leukaemia.
    Udén AM; Brenning G; Engstedt L; Franzén S; Gahrton G; Gullbring B; Holm G; Höglund S; Jameson S; Killander A; Killander D; Lockner D; Mellstedt H; Palmblad J; Reizenstein P; Skårberg KO; Swedberg B; Wadman B; Wide L
    Scand J Haematol; 1975 Aug; 15(1):72-80. PubMed ID: 1058527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experiences with daunomycin and cytosine arabinoside in the therapy of acute myeloid leukemias].
    Kreiter H; Begemann H; Rastetter J
    Med Klin; 1968 Dec; 63(51):2058-66. PubMed ID: 5255517
    [No Abstract]   [Full Text] [Related]  

  • 13. Low dose cytosine arabinoside in adult acute non-lymphoid leukemia.
    Rossi Ferrini P; Ciolli S; Leoni F
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():36-7. PubMed ID: 2713558
    [No Abstract]   [Full Text] [Related]  

  • 14. Mitoxantrone, cytosine-arabinoside and 6-thioguanine (MAT) in the treatment of newly diagnosed acute non-lymphoblastic leukemia in adults.
    Motawy MS; Khalifa F; Salfiti R; Patel JP
    Anticancer Drugs; 1992 Oct; 3(5):475-9. PubMed ID: 1450441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acute myeloid leukemia and myelodysplastic syndrome by low dose arabinosyl cytosine.
    Baccarani M; Fasola G; Fanin R; Morassi P; Florean M; Pozzato G; Cavazzini G; Zaccaria A; Guarini L; Lodi L
    Haematologica; 1985; 70(2):160-5. PubMed ID: 3924780
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with the use of cytosine arabinoside in adult acute leukaemia.
    Brodie GN; Penny R
    Med J Aust; 1970 Mar; 1(13):635-7. PubMed ID: 5267173
    [No Abstract]   [Full Text] [Related]  

  • 17. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
    Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitoxantrone and ara-C in previously treated patients with acute myelogenous leukemia.
    Paciucci PA; Dutcher JP; Cuttner J; Strauman JJ; Wiernik PH; Holland JF
    Leukemia; 1987 Jul; 1(7):565-7. PubMed ID: 3478540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose cytosine arabinoside in the initial treatment of acute leukemia.
    Barnett MJ; Waxman JH; Richards MA; Ganesan TS; Bragman KS; Rohatiner AZ; Lister TA
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):133-8. PubMed ID: 3859927
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of acute leukemia with 5-azacytidine (NSC-102816).
    McCredie KB; Bodey GP; Burgess MA; Gutterman JU; Rodriguez V; Sullivan MP; Freireich EJ
    Cancer Chemother Rep; 1973; 57(3):319-23. PubMed ID: 4127393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.